Semler Scientific, Inc.
SMLR
$32.62
-$0.98-2.92%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -17.44% | -11.93% | -4.50% | 8.22% | 20.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.44% | -11.93% | -4.50% | 8.22% | 20.28% |
| Cost of Revenue | 5.59% | -4.48% | -5.95% | -1.45% | 6.00% |
| Gross Profit | -19.07% | -12.51% | -4.39% | 9.00% | 21.44% |
| SG&A Expenses | -20.43% | -16.69% | -13.68% | -4.97% | 6.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.22% | -15.26% | -13.33% | -4.02% | 8.19% |
| Operating Income | -17.80% | -5.96% | 13.18% | 34.17% | 48.03% |
| Income Before Tax | 98.68% | -28.21% | -18.03% | 23.96% | 36.23% |
| Income Tax Expenses | 98.58% | -61.01% | -43.01% | -19.56% | 4.48% |
| Earnings from Continuing Operations | 98.70% | -18.71% | -10.82% | 36.11% | 43.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 98.70% | -18.71% | -10.82% | 36.11% | 43.69% |
| EBIT | -17.80% | -5.96% | 13.18% | 34.17% | 48.03% |
| EBITDA | -17.64% | -5.76% | 13.04% | 32.56% | 45.35% |
| EPS Basic | 73.72% | -21.25% | -12.27% | 34.69% | 43.68% |
| Normalized Basic EPS | 50.10% | -21.74% | -5.21% | 40.15% | 57.98% |
| EPS Diluted | 87.09% | -18.39% | -9.77% | 38.27% | 46.88% |
| Normalized Diluted EPS | 61.23% | -18.23% | -2.15% | 44.12% | 61.39% |
| Average Basic Shares Outstanding | 7.37% | 3.25% | 2.17% | 1.08% | 0.08% |
| Average Diluted Shares Outstanding | 1.92% | -1.32% | -1.55% | -1.83% | -2.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
